To the best of our knowledge, the molecular mechanism of PKIB in tumors is mostly understood in prostate cancer, where PKIB promotes the growth and invasion of prostate cancer cells by increasing the phosphorylation of AKT [29]. Here, AKT1 is linked to prostate carcinoma.